BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mackay TM, van Erning FN, van der Geest LG, de Groot JWB, Haj Mohammad N, Lemmens VE, van Laarhoven HW, Besselink MG, Wilmink JW. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis. European Journal of Cancer 2019;106:99-105. [DOI: 10.1016/j.ejca.2018.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Rijken A, Bakkers C, van Erning FN, van der Geest LG, de Vos-Geelen J, Besselink MG, Lemmens VE, de Hingh IHJT; Dutch Pancreatic Cancer Group. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort. Pancreas 2021;50:827-33. [PMID: 34347730 DOI: 10.1097/MPA.0000000000001857] [Reference Citation Analysis]
2 Zhang X, Feng S, Wang Q, Huang H, Chen R, Xie Q, Zhang W, Wang A, Zhang S, Wang L, Yao M, Ling Q. Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. J Cell Mol Med 2021;25:1750-8. [PMID: 33452856 DOI: 10.1111/jcmm.16281] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Li G, Liao CY, Chen JZ, Huang L, Yang C, Tian YF, Wang YT, Du Q, Zhan Q, Chen YL, Chen S. Construction and Validation of Novel Nomograms for Predicting Prognosis of Pancreatic Ductal Adenocarcinoma After Surgery According to Different Primary Cancer Locations. Front Oncol 2021;11:646082. [PMID: 33968745 DOI: 10.3389/fonc.2021.646082] [Reference Citation Analysis]
4 Strijker M, van Veldhuisen E, van der Geest LG, Busch OR, Bijlsma MF, Haj Mohammad N, Homs MY, van Hooft JE, Verheij J, de Vos-Geelen J, Wilmink JW, Steyerberg WEW, Besselink MG, van Laarhoven HW; Dutch Pancreatic Cancer Group. Readily available biomarkers predict poor survival in metastatic pancreatic cancer. Biomarkers 2021;26:325-34. [PMID: 33663300 DOI: 10.1080/1354750X.2021.1893814] [Reference Citation Analysis]
5 Fu H, Zeng J, Liu C, Gu Y, Zou Y, Chang H. Folate Intake and Risk of Pancreatic Cancer: A Systematic Review and Updated Meta-Analysis of Epidemiological Studies. Dig Dis Sci 2021;66:2368-79. [PMID: 32770489 DOI: 10.1007/s10620-020-06525-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yamamoto T, Satoi S, Yamaki S, Hashimoto D, Ishida M, Ikeura T, Hirooka S, Matsui Y, Boku S, Nakayama S, Nakamaru K, Shibata N, Katsushima U, Sekimoto M. Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit. Cancers (Basel) 2022;14:1354. [PMID: 35267661 DOI: 10.3390/cancers14051354] [Reference Citation Analysis]
7 Kitamura K, Esaki M, Sone M, Sugawara S, Hiraoka N, Nara S, Ban D, Takamoto T, Mizui T, Shimada K. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. Ann Surg Oncol 2022. [PMID: 35691957 DOI: 10.1245/s10434-022-11950-1] [Reference Citation Analysis]
8 Malleo G, Maggino L, Ferrone CR, Marchegiani G, Luchini C, Mino-Kenudson M, Paiella S, Qadan M, Scarpa A, Lillemoe KD, Bassi C, Fernàndez-Del Castillo C, Salvia R. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 2020;27:3898-912. [PMID: 32307617 DOI: 10.1245/s10434-020-08354-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zou Y, Han H, Ruan S, Jian Z, Jin L, Zhang Y, Chen Z, Yin Z, Ma Z, Jin H, Dai M, Shi N. Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail. Front Oncol 2020;10:526602. [PMID: 33194585 DOI: 10.3389/fonc.2020.526602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gao J, Huang X, Meng H, Zhang M, Zhang X, Lin X, Li B. Performance of Multiparametric Functional Imaging and Texture Analysis in Predicting Synchronous Metastatic Disease in Pancreatic Ductal Adenocarcinoma Patients by Hybrid PET/MR: Initial Experience. Front Oncol 2020;10:198. [PMID: 32158690 DOI: 10.3389/fonc.2020.00198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]